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A combined cytogeneticurine metabolite analysis approach was used to assess potential interactive effects between Fenarimol (FN), a fungicide,
and trichloroethylene (TRI), a halogenated solvent. FN was demonstrated to selectively induce P450-2B1 isoforms in different organs of treated
mice. Since the rate of metabolism and the stereospecificity of metabolism are dependent on the types and amount of P450s available, FN might
drastically alter the metabolic activation of a precarcinogen, such as TRI, and its toxicological consequences. Male CD1 mice were divided into
untreated, vehicle control, and experimental groups. Animals of the latter groups were treated ip with 150 mg/kg bw FN in corn oil, 457 mg/kg bw
TRI in corn oil, TRI plus FN separated by different time intervals. Bone marrow cells were harvested for determination of micronuclei (MN) frequen-
cies in polychromatic erythrocytes (PCE). The presence of the known metabolite of TRI, trichloroethanol (TCE), was quantitated in collected urine by
gas chromatography using an electron-capture detector. Linear regression analysis shows that MN frequency by TRI is correlated with TCE concen-
tration in urine. Observed potentiation of genotoxicity of TRI by FN pretreatment (1 hr before TRI treatment) apparently reflects changes in the spec-
tra of enzymes involved in TRI metabolism, and altered toxicokinetic, as witnessed by the 20% difference in TCE excretion from combined treated
mice. However, no increased genetic or metabolic effects were observed when FN was administered 3 hr before TRI. No significant interactive
effects were observed at a genetic level when FN was administered 1 hr and 3 hr after TRI whereas a 33 to 47% loss in TCE excretion was
recorded. On the other hand, concomitant exposure to TRI and FN caused decreased TRI metabolic levels and decreased genetic effects by TRI
through its metabolites probably due to an inactivation of microsomal enzymes critical for TRI metabolism. However, exposure to combined treat-
ment at any time interval has an overall genotoxicity lower than that calculated by a simple additivity model.-Environ Health Perspect 102(Suppl
91:31-34 (1994)
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Introduction
The increase in concern over the health
hazard associated with the use of multiple
pollutants is a growing awareness of the
hazard associated with long-term exposure
to some of these environmental carcino-
gens. Concurrent or sequential exposure to
several xenobiotics may occur in air, water,
and food. A realistic scenario is groundwa-
ter contamination related to hazardous
waste disposal and agriculture activities.
Pesticides have properties invaluable to
modern industrial society; however they
can induce a wide array of health effects,
ranging from myelotoxicity to cytogenetic
changes and carcinogenic effects.
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A preliminary study on the mutagenic/
carcinogenic potential of pesticides indi-
cated that several agents are toxic but poor
initiating agents, as shown by negative or
weak positive results at different genetic
end points (1,2). On the other hand, bio-
chemical and immunochemical studies
showed that a number of pesticides
induced specific P450 isoforms in different
organs ofrodents (3). This inductive capa-
bility may be responsible for pharmacoki-
netic interactions with other xenobiotics,
and in particular, alter the metabolic acti-'
vation ofprecarcinogens and their toxico-
logical consequences.
This study was designed to evaluate if
exposure to Fenarimol (FN), a fungicide,
previously demonstrated to selectively
induce P450-2B1 isoforms in liver, kidney,
and lung oftreated mice (3), may alter the
rates of biotransformation and the toxic
effects of a carcinogen such as trichloro-
ethylene (TRI).
TRI is a versatile solvent with numer-
ous commercial, industrial, household, and
pharmacological applications. It is com-
monly found in waste disposal sites and is a
frequent contaminant ofboth surface and
groundwaters (4). TRI is rapidly absorbed
and metabolized extensively in a multistep
process (5-7). Through an apparent oxide
intermediate, TRI can form chloral
hydrate, which undergoes oxidation to
trichloroacetic acid. Alternatively, chloral
hydrate can be metabolized to trichloro-
ethanol (TCE), which undergoes phase II
glucuronidation to produce TCE-glu-
curonide and accounts for approximately
94% of the total urinary metabolism in
mice (7). Under certain conditions, the
oxide intermediate can form dichloroacetic
acid (6,7). Trichloroacetate, dichloroac-
etate and chloral hydrate are postulated as
reactive metabolites ofTRI responsible for
induction ofDNAdamage (8).
Since the rate-limiting step in the over-
all metabolism ofTRI is the step from TRI
to chloral hydrate, which is catalyzed by
cytochrome P450, changes in TRI metabo-
lism and toxicity produced by FN may
result from differences in the catalytic
properties ofthe enzymes induced by FN.
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A combined cytogenetic and toxicoki-
netic study was performed by using reliable
biomarkers to assess interaction at genetic
level (as quantitated by the frequency of
micronucleated polychromatic erythrocytes
in mice) and metabolic level (in terms of
urinary excretion ofTCE) between FN and
TRI. Results obtained contribute to a
mechanistic interpretation ofthese interac-
tions and provide information on their
implication to human health.
Materials and Methods
Chemicals
Reagent grade FN (CAS no. 60168-88-9)
was purchased from Lab Service Analytic
(Bologna, Italy); TRI was from Janssen
(Beerse, Belgium). TCE, a-Cellulose,
Cellulose Type 50, Acridine Orange, and
P-glucuronidase Type M-3 were purchased
from Sigma Co (St. Louis, MO); fetal calf
serum (FCS) and HBSS solution were sup-
plied by GIBCO-BRL (UK).
Animals andTreatment
Adult male Swiss albino CD1 mice (30 ±2 g)
were purchased from Nossan (Correzzano,
Italy). Theywere housed in the animal facility
which had 12 hr day-night cycles and tem-
perature and humidity controls. Purchased
animals were allowed a 1 week acclimation
period before beginningtreatment.
FN and TRI were dissolved in corn oil
immediately before administration to mice
ip with avolume of0.01 ml/gbwtreatment.
Groups of five mice were assigned to
group as negative control, solvent control,
and exposure (457 mg/kg bw TRI and 150
mg/kg bw FN). To investigate the interac-
tive effects between TRI and FN, FN was
administered to mice 3 hr and 1 hr before
and at 0 hr, 1 hr, and 3 hr after TRI ad-
ministration. Metabolic studywas also con-
ducted with these groups and compared to
the group exposed to TRI alone.
Urine CollectionandMetabolite
Analysis
Different treated groups were housed sepa-
rately in clean metabolic cages containing
food and drinking water. The urine from
each group of five mice was collected for
24 hr in glass tubes. The exact volume of
urine collected from each group was mea-
sured, then every urine sample was cen-
trifuged at 1500 rpm for 10 min. The
presence ofthe known principal metabolite
ofTRI, TCE, was quantitated in collected
urine by gas chromatography using an elec-
tron-capture detector (GC-ECD) (9).
TCE was excreted with the urine in the
form of its glucuronide and, before gas
chromatography determination, it was
hydrolyzed enzymatically. Therefore, 0.1
ml ofurine was pipetted into glass ampules
and brought to a volume of 1.0 ml with
distilled water followed by the addition of
1.0 ml acetate buffer (0.5 M, pH 4.5) con-
taining P-glucuronidase. The ampules were
allowed to react at 37°C for 18 hr. After
cooling, the solution was appropriately
diluted with acetone.
Gas chromatography operating condi-
tions for TCE determination were: gas
chromatograph 6000 Model Vega (Carlo
Erba, Milan, Italy) equipped with a 63Ni
electron-capture detector and integrator SP
4270 Model Vega; stainless steel column
(30 m length, 0.32 mm diameter); carrier
gas: helium (30 m/sec); column: fused sil-
ica on RTX 200 (0.5 p); temperature:
injection part 240°C, detector 310°C;
analysis program: 400C for 6 min, then
from 40°C to 150°C (15C/min).
Micronudei (MN) Analysis
Mice were killed 30 hr after treatment for
the single-treatment groups and after the
first treatment for the combined-treatment
groups. In order to study the frequency of
MN in mouse bone marrow, the femoral
cells were flushed out with FCS; the cellu-
lar suspension was added on a column of
about 2.0 cm height of cellulose Type 50
and x-cellulose and washed out with HBSS
solution with a drop speed of 15 drops/
min, according to Selig et al. (10).
The cells collected were sedimented by
centrifugation (5 min, 1800 rpm) and after
resuspension ofpellet in FCS prepared on
microscopical slides. After air drying, the
cells were fixed in methanol for 15 min and
then dipped in fresh phosphate buffer
(0.66% w/v potassium phosphate mono-
basic and 0.32 % w/v sodium phosphate
dibasic, pH 6.4-6.5). Then they were
stained in a solution ofAcridine Orange
(AO) (12.5 mg AO/100 ml buffer) for 60
sec (11). The slides were then allowed to
stand in buffer for 10 min, mounted using
the phosphate buffer, and observed for the
presence ofMN in polychromatic erythro-
cytes (PCE). The data were summarized as
the mean number ofmicronucleated PCE
for 1000 PCE.
In addition, the ratio between the PCE
and normochromatic erythrocytes (NCE)
were also determined.
StatisticalAnalysis
The data were evaluated by the chi-square
test to compare the MN frequency between
Table 1. Time-course study on the clastogenic effect
oftrichloroethylene in bone marrow cells of mice.a
Hours after PCE with MN/
treatment 1000 cells PCE/NCE
24 5.00 ± 0.71 0.85 ± 0.01
30 9.60 ± 0.68 0.86 ± 0.02
48 6.00 ± 0.71 0.80 ± 0.02
Abbreviations: PCE, polychromatic erythrocytes; MN,
micronuclei; NCE, normochromatic erythrocytes.aMice
were administered a single dose of trichloroethylene
(457 mg/kg) ip. There were five mice per group and
1000 PCE were examined per mouse. Data indicate
means ± S.E.M.
treated groups (12). Linear regression
analysis was calculated to determine the
relationship between the level ofbone mar-
row MN and the changes in the levels of
TCE in urine.
Results
Induction ofMicronudei andEffects
on Cell Proliferation
As detectable changes in activity of P450-
linked enzymes were recorded only in ani-
mals treated with doses of FN ranging
from 150 to 300 mg/kg bw (3), 150
mg/kg FN (25% DL5o) was chosen as
experimental dose.
Data from the preliminary time-course
study on the clastogenic effects ofTRI in
bone marrow cells of mice showed that
TRI induces the major MN frequency at
30 hr after treatment (Table 1). For this
reason 30 hr was chosen as the experimen-
tal time. Very low MN frequencies were
observed in untreated and vehicle-treated
control mice (2.00 and 2.40 MN/1000
PCE, respectively) (Table 2).
From the data ofthe combined treat-
ments reported in Table 2, mice treated
with FN and 3 hr later with TRI showed
an induced frequency of 8.77 MN/1000
PCE similar to the frequency of 9.00
MN/1000 PCE caused by TRI alone.
However, the groups exposed to FN and 1
hr later to TRI, showed a highly significant
increase (p<0.01) in the frequency ofMN
in PCE with respect to TRI-exposed
group. Simultaneous exposure to FN and
TRI induced a marked decrease (p<0.05) in
the MN frequency with respect to TRI
exposure, and significantly reduced the
PCE/NCE ratio. These results may be due
to the toxicity ofsimultaneous administra-
tion of the compounds in mice, which led
to a depression of the erythropoiesis.
Increasing the interval between TRI and
FN from 1 hr to 3 hr led to slight but not
significant enhancement effects, the fre-
quencies being from 10.80 to 11.20
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MN/1000 PCE, respectively. These com-
bined treatments did not affect the
PCE/NCE ratio, and their values were
comparable to control.
Mice treated with FN showed a signifi-
cant increase (p<0.01) in MN in PCE over
the control (Table 2). On the other hand
the increases after combined treatments
with TRI at any time intervals were less
than the expected value (MN = 18.2/1000)
based on the simple sum of the effects of
the individual compounds.
UrineMetaboliteAnalysis
The principal breakdown product ofTRI
in urine, TCE, in mice was measured in
relation to the different exposures. After the
combined treatments, when FN was
administered 3 hr beforeTRI, TCE content
did not show any appreciable change with
respect to the excretion in urine of mice
treated with TRI alone. However, reducing
the interval between FN and TRI from 3 to
1 hr, there was an alteration in the excretion
ofTCE, as witnessed by the 20% difference
in TCE quantity (Figure 1) recorded in
group exposed to combined treatment com-
pared to treatment with TRI alone.
On the other hand, groups treated with
TRI first, followed 0, 1, and 3 hr later with
FN demonstrated a decrease in TCE quan-
tity, being the 49, 53, and 67% ofcontrol
(TmJ-alone treated mice), respectively.
Discussion
In addition to genotoxicity assays, biochem-
ical studies are recommended to be used to
Table 2. Frequency of polychromatic erythrocytes
(PCE) with micronuclei (MN) in mice exposed to
trichloroethylene (TRI) and Fenarimol (FN).
PCE with MN/
Exposurea 1000 cells PCE/NCEb
Negative control 2.00 ± 0.45 0.80 ± 0.01
Solvent control 2.40 ± 0.24 0.80 ± 0.01
(corn oil)
Positive control 9.00 ±0.89c 0.78 ±0.02
TRI (457 mg/kg)
FN (150 mg/kg 9.20 ± 1.07c 0.77 ± 0.02
FN +TRI (3 hrapart) 8.77 ± 1.20c 0.75 ±0.07
FN +TRI (1 hrapart) 16.40 ±2.01d 0.75 ±0.06
TRI + FN (0 hr) 5.60 ±0.51e 0.63 ±0.02f
TRI + FN (1 hr) 10.80 ± 1.39 0.87 ± 0.06
TRI + FN (3 hr) 11.20 ± 1.39 0.77 ± 0.01
aEach exposure group contains five mice and 1000 PCE
were examined for each animal. The data are the
mean ± S.E.M. bNCE, normochromatic erythrocyte.
CSignificantly different from the control group (p<0.01,
chi-square test). dSignificantly different from the TRI-
exposed group (p< 0.01, chi-square test). eSignificantly
different from the TRI-exposed group (p< 0.05, chi-
square test). fSignificantly different from the control
group(p<0.01, Students' t-test).
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Figure 1. Comparison of responses in mice exposed to Fenarimol (FN) and trichloroethylene (TRI). Time-dependent
responses of MN induction and cumulative excretion oftrichloroethanol (TCE) in urine (expressed as mg/kg bw)
are plotted with TRI alone effects normalized to 1. A linear correlation (r= 0.76) was found between the frequency
of MN and TCE levels recorded within 24 hr.
obtain information that is useful in the
evaluation ofthe mechanism ofaction ofa
chemical and risk identification (3). In fact,
changes in the spectra ofenzymes involved
in carcinogen metabolism may dramatically
alter pharmacokinetic and toxicological
consequences ofa precarcinogen (9).
It is demonstrated that TRI requires
metabolic activation in order to express its
genotoxic activity in vivo (8). At least three
isoenzymes of P450 appear to be involved
in activation ofTRI and, in particular, the
P450-2B1 linked enzymes and the P450-
2E1 class (13).
Significant changes in the P450-2B1-
dependent oxidases were observed after sin-
gle and repeated treatment with FN from
the dose of 150 mg/kg (3). The time-
course induction following FN showed
that the maximum induction with FN was
apparent in animals after 72 hr of treat-
ment (three daily injections). This was con-
firmed by immunochemical analysis (3).
Lower doses of FN did not cause any
detectable changes in the activity of P450
species.
Our working hypothesis was that the
fungicide FN, by inducing P450 isoen-
zymes similar to those responsible for TRI
metabolism (P450-2B1) may alter the rates
of TRI biotransformation and its clasto-
genic activity in mice. The importance of
metabolism in toxic response by TRI was
demonstrated by others in rodents pre-
treated with different inducers (13-15).
Our genotoxicity and toxicokinetic
studies show that FN can affect the metab-
olism of TRI. In fact, the relationship
between genetic damage by TRI as quanti-
tated by MN frequency, and metabolism of
TRI evaluated in terms ofurinary excretion
ofTCE and investigated by comparing the
time-response curves, shows that the shape
of the curve for MN resembles that for
TCE excretion (Figure 1). Furthermore, a
linear correlation is shown (r = 0.76)
between the induction of MN and urinary
levels ofTCE recorded within 24 hr.
The increased urinary excretion ofTCE
and the significant increases in MN pro-
duced by TRI after 1 hr pretreatment with
FN apparently suggest not only that TRI
metabolites are necessary for DNA damage
to occur, but also that FN can induce bio-
chemical pathways involving the active
metabolites ofTRI and contribute to the
induction of MN by TRI. Similar results
were found with phenobarbital, which
increased the extent ofliver injury (13) and
in vivo strand breaks in DNA (9) following
exposure to TRI, through its metabolites
ethanol (16), 3-methylcholanthrene (14),
and other inducers of the hepatic mixed
function oxidase system (13,15). However,
no increased effects by TRI were observed
when FN pretreatment was extended to 3 hr.
Unlike pretreatment with FN, simulta-
neous exposure to FN and TRI results in a
suppression ofTRI's metabolism, as evi-
denced by decreased TRI metabolite levels
in the urine oftreated mice, and decreased
genetic effects as compared to animals
treated with TRI alone. This phenomenon
may be due to an inactivation ofthe micro-
somal enzymes that are responsible for TRI
metabolism, since both TRI and FN are
substrates of the same P450 isoenzymes.
More work is needed to elucidate the bio-
chemical basis of this interaction.
Suppression of TRI's metabolism and
reduced TRI metabolite levels in urine
were also demonstrated with exposure to
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TRI and other solvents in dry cleaning
workers (17). However, a direct interac-
tion between the clastogenic effects of the
two compounds can not be excluded.
Investigation into the genotoxicity of
FN are suggestive of clastogenic effects in
vivo (3,18). The effect ofexposure to two
agents capable ofproducing the same geno-
toxic effect (induction of micronucleated
erythrocytes in mice) may lead to additive
or synergistic effects. Combined adminis-
tration ofTRI and FN to mice does not
result in additive or synergistic effects in
induction ofgenetic damage, but rather to
an antagonistic effect. In fact, the observed
increases in micronucleated erythrocytes in
our time-course study were lower than the
expected value based on the summation of
the effects ofthe two toxicants.
In conclusion, this study pointed out
that even if FN treatment enhances TRI
metabolism towards the production of
more genotoxic metabolite(s), the exposure
to the mixture of FN and TRI does not
increase clastogenesis in vivo. Inductive sta-
tus has usually been associated with
increased mutagenic/carcinogenic risk,
even ifthis view has been demonstrated to
be too restrictive (9). Caution should be
exercised, therefore, in making broad gen-
eralizations concerning the effects ofmicro-
somal enzyme inducers on the toxicity of
xenobiotics and the double-edged-sword
nature of this phenomenon must be con-
sidered case by case.
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